Vertex Pharmaceuticals Incorporated
DNA-PK inhibitors

Last updated:

Abstract:

The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Status:
Grant
Type:

Utility

Filling date:

13 Aug 2019

Issue date:

18 May 2021